Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapeutic Duration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03409770
What this trial is testing

Optimising the Duration of Cooling in Mild Encephalopathy

Who this might be right for
Neonatal EncephalopathyHypothermia NeonatalMagnetic Resonance Spectroscopy
Thayyil, Sudhin 140
Post-approval studies (Phase 4)Study completedNCT02047773
What this trial is testing

Bacterial Load Guided Therapy for Severe Bronchiectasis Exacerbations

Who this might be right for
Bronchiectasis
University of Edinburgh 90
Large-scale testing (Phase 3)Study completedNCT02432105
What this trial is testing

Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT)

Who this might be right for
Otitis Media With Effusion in ChildrenOtitis Media Recurrent
Alcon Research 470
Not applicableStudy completedNCT06085820
What this trial is testing

The Effect of Birth Ball and Birth Dance Applied in the First Stage of Labor on Some Parameters

Who this might be right for
Pain, LaborSatisfaction, Patient
Amasya University 104
Testing effectiveness (Phase 2)Ended earlyNCT02013765
What this trial is testing

Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer

Who this might be right for
Urinary Tract Cancer
Hoffmann-La Roche 5
Not applicableStudy completedNCT01354665
What this trial is testing

Depression and Fatigue in MS Patients Treated With Betaferon.

Who this might be right for
Multiple Sclerosis
Bayer 567
Early research (Phase 1)Study completedNCT02248298
What this trial is testing

Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic Keratosis

Who this might be right for
Actinic Keratosis
Dong-A University 93
Not applicableStudy completedNCT04568681
What this trial is testing

Deep Brain Stimulation Effects in Dystonia

Who this might be right for
Dystonia
University of Florida 7
Not applicableStudy completedNCT01278030
What this trial is testing

Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selection to Reduce Cardiac Resynchronization Therapy Non-Responder Rates

Who this might be right for
Heart Failure
Abbott Medical Devices 78
Not applicableLooking for participantsNCT05788744
What this trial is testing

Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer
Copenhagen University Hospital at Herlev 1,000
Post-approval studies (Phase 4)Study completedNCT00822536
What this trial is testing

Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation

Who this might be right for
Coronary Artery DiseaseStent ThrombosisMyocardial Ischemia
Assistance Publique - Hôpitaux de Paris 1,798
Post-approval studies (Phase 4)Study completedNCT00121836
What this trial is testing

Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 109
Not applicableNot Yet RecruitingNCT07259434
What this trial is testing

Time Restricted Eating in Survivors Trial 2.0

Who this might be right for
Breast CancerCardiovascular RiskCognitive Function+1 more
University of Toronto 152
Testing effectiveness (Phase 2)Looking for participantsNCT04908228
What this trial is testing

Fixed-duration Therapy With Ibrutinib and Obinutuzumab (GA-101) in Treatment-naïve Patients With CLL

Who this might be right for
Chronic Lymphocytic Leukemia
Paolo Ghia 53
Large-scale testing (Phase 3)Study completedNCT02243644
What this trial is testing

Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT

Who this might be right for
Neurocysticercosis
All India Institute of Medical Sciences 97
Post-approval studies (Phase 4)Ended earlyNCT00190463
What this trial is testing

Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia

Who this might be right for
Malignant HemopathyDuration of Neutropenia Following Chemotherapy > 10 Days
Assistance Publique - Hôpitaux de Paris 300
Testing effectiveness (Phase 2)Study completedNCT00558363
What this trial is testing

ARTS - AVODART After Radical Therapy For Prostate Cancer Study

Who this might be right for
Neoplasms, ProstateProstate Cancer After a Radical Treatment
GlaxoSmithKline 294
Not applicableNot Yet RecruitingNCT07092904
What this trial is testing

Myocardial Infarction Safe Emergency Medicine Accompanying Study: Providing Reperfusion Therapy Within the Recommended Time Limits

Who this might be right for
Infarction
University Hospital of North Norway 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT05677919
What this trial is testing

Pirtobrutinib and Venetoclax With MRD Detection for Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Mayo Clinic 72
Not applicableStudy completedNCT04497467
What this trial is testing

Changes in Out-patient Visits in Taiwan During the Time of Global COVID-19 Pandemic

Who this might be right for
Patient Preference
National Taiwan University Hospital 1,200,000
Next Page